A federal grand jury in San Francisco has indicted a California-based telehealth company and a Florida medical practice for allegedly orchestrating a massive scheme to illegally distribute Adderall, commit health care fraud, and obstruct justice—an indictment that highlights growing failures in telehealth oversight.

According to the Department of Justice, Done Global Inc.—which marketed itself as a “digital health company”—used a subscription-based model to unlawfully distribute more than 40 million pills of Adderall and other stimulants, generating over $100 million in revenue. A Florida practice, Mindful Mental Wellness P.A., was allegedly created to help continue the scheme after pharmacies began refusing Done-affiliated prescriptions.

Federal prosecutors say Done Global exploited telehealth loopholes to bypass basic medical safeguards, instructing prescribers to issue stimulant prescriptions without legitimate medical purpose.

“Done Global used lies and deceit to carry out a sophisticated and wide-ranging telehealth fraud scheme,” said Acting Assistant Attorney General Matthew Galeotti.

Telehealth as a Distribution Pipeline

Court documents allege prescriptions were routinely issued without in-person examinations, without established doctor-patient relationships, and in some cases without any video or audio interaction at all. Patients allegedly did not meet DSM-V criteria for ADHD, posed diversion risks, or were prescribed dosages and combinations far outside accepted medical practice.

Instead of using technology to expand access to care, prosecutors allege Done Global weaponized telehealth to maximize profit.

“Controlled substances are not commodities to be marketed through memberships,” said DEA Assistant Administrator Cheri Oz.

The indictment alleges Done Global and its partners offered few treatment options beyond stimulants—turning medical care into a pharmaceutical pipeline.

Defrauding Federal Programs and Obstructing Justice

Prosecutors further allege Done Global submitted false and fraudulent claims to Medicare, Medicaid, and commercial insurers, disguising unlawful prescriptions to obtain reimbursement. When pharmacies began blocking Done-affiliated providers in 2023, the company allegedly incorporated the Florida practice to circumvent restrictions.

The indictment also charges Done Global with conspiracy to obstruct justice, alleging executives altered, destroyed, or concealed records after receiving a grand jury subpoena.

“Running a sham operation to exploit federal programs is a blatant abuse,” said HHS-OIG Deputy Inspector General Christian Schrank.

Regulatory Failure with Real Consequences

The case exposes a broader regulatory failure: telehealth expanded rapidly during COVID-era emergency policies, but enforcement lagged behind. As this indictment shows, inadequate oversight allowed controlled substances to be prescribed at industrial scale—placing patient safety and public health at risk.

Done Global’s founder Ruthia He and former clinical president David Brody were previously convicted of controlled-substance and health care fraud conspiracies, underscoring the alleged criminal nature of the operation.

Charges and Accountability

Done Global faces charges including conspiracy to illegally distribute Adderall, health care fraud, and obstruction of justice. If convicted, the company faces penalties of up to twice the gross profits or losses tied to the scheme. Mindful Mental Wellness faces similar exposure.

Federal officials emphasized that telehealth remains a legitimate tool—but warned that abuse of digital medicine undermines trust in the health care system.

An indictment is merely an allegation. All defendants are presumed innocent until proven guilty beyond a reasonable doubt.